E Fund Management Co., Ltd. Viridian Therapeutics, Inc.\De Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.09 - $23.82 $144,376 - $201,231	8,448 Added 77.68%	19,323 $338,000
Q4 2023 Feb 06, 2024	SELL	$11.12 - $22.5 $28,489 - $57,645	-2,562 Reduced 19.07%	10,875 $236,000
Q3 2023 Nov 13, 2023	BUY	$15.16 - $24.7 $4,775 - $7,780	315 Added 2.4%	13,437 $206,000
Q2 2023 Aug 11, 2023	BUY	$22.57 - $29.67 $69,470 - $91,324	3,078 Added 30.65%	13,122 $312,000
Q1 2023 May 11, 2023	BUY	$25.04 - $37.6 $251,501 - $377,654	10,044 New	10,044 $256,000

179

76.8M

581K

439K

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $806M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.